Abstract
Background analysis of fetal/placental components of women with gestational diabetes presented a slightly inflammatory profile, compared with non-diabetic pregnant women in previous studies by our group. Leptin, resistin and IL-6 are involved in the inflammatory process while adiponectin can act in anti-inflammatory processes.
Purpose Since both obesity and gestational diabetes are associated with inflammatory conditions, through these mediators we seek to evaluate systemic patterns in pregnant women and fetal patterns of this possible inflammation.
Materials and Methods Three adipokines (leptin, resistin and adiponectin) and one cytokine (IL-6) were studied in three different compartments (maternal serum, fetal serum and amniotic membrane culture supernatant). Four pregnant groups were analyzed (eutrophic, overweight, obese and gestational diabetics (GDM)). Maternal and fetal serum and amnion membrane biopsies were collected from 20 GDM and 28 normoglycemic subjects (Controls) who underwent elective cesarean sections.
Results We found a higher production of IL-6 in the culture supernatant of the amniotic membrane of obese pregnant women and more significantly in pregnant women with gestational diabetes. We did not observe correlation between the levels of mediators detected in the three compartments (mother serum, fetal serum and culture supernatant of amniotic membrane).
Conclusion Mainly in the amniotic membrane of pregnant women with GDM, a slight increase in inflammatory markers was observed.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://pubmed.ncbi.nlm.nih.gov/33836321/
Funding Statement
This work was supported by the Sao Paulo Research Foundation (FAPESP) [Grant number 2016/16807-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [Grant number 302969/2019-5]; and by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Obstetric Center of Hospital Sao Paulo-Brazil. Ethics and Research Committee of UNIFESP CAAE 80728417.8.0000.5505
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
